Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate.

Photopheresis is being used with increasing frequency as therapy for patients with neoplastic and dermatologic diseases and is being evaluated as therapy for patients with AIDS. We describe a patient with advanced cutaneous T cell lymphoma who developed pulmonary and cutaneous cryptococcosis after receiving therapy with photopheresis and biweekly methotrexate. We consider the potential roles of cutaneous T cell lymphoma, methotrexate, and photopheresis as predisposing factors in the development of serious cryptococcal infections.

[1]  R. Edelson,et al.  Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. , 1994, Archives of dermatology.

[2]  F. Gasparro,et al.  Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. , 1992, Journal of the American Academy of Dermatology.

[3]  R. Balderas,et al.  Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome. , 1992, The American journal of pathology.

[4]  E. Vonderheid,et al.  Infections complicating mycosis fungoides and Sézary syndrome. , 1992, JAMA.

[5]  S. Jimenez,et al.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. , 1992, Archives of dermatology.

[6]  R. Madhok,et al.  Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. , 1992, British journal of rheumatology.

[7]  C. Berger,et al.  Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. , 1990, Annals of internal medicine.

[8]  A. Rook,et al.  Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. , 1990, Annals of internal medicine.

[9]  M. Tanimoto,et al.  Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group , 1989, Blood.

[10]  L. Laroche,et al.  Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. , 1989, The Journal of investigative dermatology.

[11]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[12]  I. Todd,et al.  Mycosis fungoides—response to therapy and survival patterns in 85 cases , 1987, The British journal of dermatology.

[13]  E. Delzell,et al.  Second malignancies in cutaneous T cell lymphoma. , 1984, Journal of the American Academy of Dermatology.

[14]  K. Yamaguchi,et al.  A proposal for smoldering adult T-cell leukemia: a clinicopathologic study of five cases , 1983 .

[15]  P. Schein,et al.  Cutaneous T‐cell lymphoma , 1976, Cancer.

[16]  T. Mochizuki,et al.  [A case of Sèzary syndrome with disseminated cryptococcosis (author's transl)]. , 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[17]  E. Vonderheid,et al.  Chronic herpes simplex infection in cutaneous T-cell lymphomas. , 1980, Archives of dermatology.

[18]  P. C. van Voorst Vader,et al.  Herpes zoster-varicella in cutaneous T-cell lymphomas. , 1980, Archives of dermatology.

[19]  E. Weiss,et al.  Pneumocystis Carinii Pneumonia: Percutaneous Lung Biopsy and Review of Literature , 1971 .